Trial intelligence / Profile preview

Pentoxifylline for Anemia in Hemodialysis Patients

NCT05708248Unknown

Sponsor
Alexandria University
Start
Feb 2023
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in anemia comparing Pentoxifylline + SOC with Standard of Care (2 arms). Primary endpoints: Variation in Hemoglobin levels at 6 months, Variation in Hypoxia inducible factor-2 alpha levels at 6 months and 3 more. Status: unknown.

02

Drugs

pentoxifylline
03

Conditions

anemia

Beyond the preview

Go deeper on NCT05708248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05708248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call